This approach was first shown to markedly reduce renal cyst formation and fibrosis and limit disease progression in a polycystic kidney rat model of ARPKD (PCK) and the pcy/Nphp3 mouse model (Gattone et al., 2003). This evidence concerns the gene NPHP3 and cystic kidney disease.